FRX vs. PLI, ABCN, EMC, MDNA, BCT, IPA, SVA, ONC, SCYB, and COM
Should you be buying Fennec Pharmaceuticals stock or one of its competitors? The main competitors of Fennec Pharmaceuticals include ProMetic Life Sciences (PLI), VIVO Cannabis (ABCN), Emblem (EMC), Medicenna Therapeutics (MDNA), BriaCell Therapeutics (BCT), ImmunoPrecise Antibodies (IPA), Sernova (SVA), Oncolytics Biotech (ONC), Scythian Biosciences (SCYB), and 138267 (COM.TO) (COM). These companies are all part of the "biotechnology" industry.
Fennec Pharmaceuticals (TSE:FRX) and ProMetic Life Sciences (TSE:PLI) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, valuation, institutional ownership, earnings, analyst recommendations, community ranking, risk, media sentiment and profitability.
Fennec Pharmaceuticals has a net margin of 6.33% compared to ProMetic Life Sciences' net margin of 0.00%. ProMetic Life Sciences' return on equity of 0.00% beat Fennec Pharmaceuticals' return on equity.
In the previous week, Fennec Pharmaceuticals' average media sentiment score of 0.00 equaled ProMetic Life Sciences'average media sentiment score.
ProMetic Life Sciences received 339 more outperform votes than Fennec Pharmaceuticals when rated by MarketBeat users. However, 69.59% of users gave Fennec Pharmaceuticals an outperform vote while only 67.69% of users gave ProMetic Life Sciences an outperform vote.
53.3% of Fennec Pharmaceuticals shares are held by institutional investors. 17.3% of Fennec Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Fennec Pharmaceuticals has higher revenue and earnings than ProMetic Life Sciences. ProMetic Life Sciences is trading at a lower price-to-earnings ratio than Fennec Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.
Summary
Fennec Pharmaceuticals beats ProMetic Life Sciences on 9 of the 11 factors compared between the two stocks.
Get Fennec Pharmaceuticals News Delivered to You Automatically
Sign up to receive the latest news and ratings for FRX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding FRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Fennec Pharmaceuticals Competitors List
Related Companies and Tools
